Minerva Neurosciences, Inc

NERV

$2.51

Name : Minerva Neurosciences, Inc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $124,837,280.00

EPSttm : -33.83

Minerva Neurosciences, Inc

$2.51

0.60%

$0.015

NERV — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.39

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

1.41

EPS Last/This Y

1.32

EPS This/Next Y

0.15

Price

2.47

Target Price

10.33

Analyst Recom

1.67

Performance Q

-36.48

Upside

-40,427.3%

Beta

0.01

Ticker: NERV

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	NERV	2.89	N/A	N/A	0
2026-10-13	NERV	2.52	0.29	999.99	18
2026-10-14	NERV	2.33	0.29	999.99	18
2026-10-15	NERV	2.41	0.29	999.99	18
2026-10-16	NERV	2.37	0.07	999.99	15
2026-10-19	NERV	2.34	0.00	0.00	13
2026-10-20	NERV	2.55	0.00	999.99	463
2026-10-21	NERV	2.38	0.00	999.99	463
2026-10-22	NERV	2.38	0.00	0.00	464
2026-10-23	NERV	2.29	0.00	0.00	464
2026-10-26	NERV	2.19	0.00	999.99	465
2026-10-27	NERV	2.22	0.00	999.99	466
2026-10-28	NERV	2.21	0.01	0.00	467
2026-10-29	NERV	2.23	0.01	1.00	468
2026-10-30	NERV	2.31	0.01	1.00	468
2026-11-02	NERV	2.34	0.01	999.99	470
2026-11-03	NERV	2.36	0.01	999.99	471
2026-11-04	NERV	2.53	0.03	6.67	478
2026-11-05	NERV	2.295	0.07	999.99	501
2026-11-06	NERV	2.4	0.07	0.33	502
2026-11-09	NERV	2.63	0.07	0.00	506
2026-11-10	NERV	2.48	0.07	0.25	507
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	NERV	2.87	-	-	-0.57
2026-10-13	NERV	2.52	-	-	-0.57
2026-10-14	NERV	2.34	-	-	-0.57
2026-10-15	NERV	2.40	-	-	-0.57
2026-10-16	NERV	2.36	-	-	-0.57
2026-10-19	NERV	2.33	-	-	-0.57
2026-10-20	NERV	2.33	-	-	-0.57
2026-10-21	NERV	2.53	-	-	-0.57
2026-10-22	NERV	2.40	-	-	-0.57
2026-10-23	NERV	2.29	-	-	-0.57
2026-10-26	NERV	2.19	-	-	-0.57
2026-10-27	NERV	2.22	-	-	-0.57
2026-10-28	NERV	2.20	-	-	-0.57
2026-10-29	NERV	2.24	-	-	-0.57
2026-10-30	NERV	2.32	-	-	-0.57
2026-11-02	NERV	2.35	-	-	-0.57
2026-11-03	NERV	2.36	-	-	-0.57
2026-11-04	NERV	2.53	-	-	-0.57
2026-11-05	NERV	2.29	-	-	-0.57
2026-11-06	NERV	2.41	-	-	-0.57
2026-11-09	NERV	2.62	-	-	-0.57
2026-11-10	NERV	2.47	-	-	-0.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	NERV	0.00	7.04	6.46
2026-10-13	NERV	0.00	7.04	6.46
2026-10-14	NERV	0.00	7.04	6.46
2026-10-15	NERV	0.00	7.04	6.46
2026-10-16	NERV	0.00	7.04	6.46
2026-10-19	NERV	0.00	7.04	6.46
2026-10-20	NERV	0.00	7.04	6.46
2026-10-21	NERV	0.00	7.04	6.46
2026-10-22	NERV	0.00	7.04	6.46
2026-10-23	NERV	0.00	7.04	6.46
2026-10-26	NERV	0.00	6.53	6.46
2026-10-27	NERV	0.00	6.53	6.39
2026-10-28	NERV	0.00	6.53	6.39
2026-10-29	NERV	0.00	6.53	6.39
2026-10-30	NERV	0.00	6.53	6.39
2026-11-02	NERV	0.00	3.26	6.39
2026-11-03	NERV	0.00	3.26	6.39
2026-11-05	NERV	0.00	3.26	6.39
2026-11-06	NERV	0.00	3.26	6.39
2026-11-09	NERV	0.00	2.91	6.39
2026-11-10	NERV	0.00	2.91	6.39
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.6

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

Institutional Transactions

2.91

Beta

0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

83.8

Max Drawdown 5-Year %

-90

Target Price

10.33

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-28.69

Average EPS Est. Cur. Y

-0.57

EPS Next Y. (Est.)

-0.42

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.56

Return on Equity vs Sector %

271.9

Return on Equity vs Industry %

291.7

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.37

EBIT Estimation

◆ NERV Healthcare

$2.49

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

5/10

RSI

45.1

Range 1M

39%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

13/30

Estimates

0/20

Inst/Vol

4/15

Options

7/10

EPS Yr

-4.9%

EPS NY

66.4%

52W%

7.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +314.9% upside

Quality

3/30

Valuation

16/30

Growth

9/25

Stability

8/10

LT Trend

1/5

Upside

+314.9%

Quality

NERV — P/E HistoricalBiotechnology

Minerva Neurosciences, Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

NERV

Latest News

—

Caricamento notizie per NERV…

stock quote shares NERV – Minerva Neurosciences Inc. Stock Price stock today

news today NERV – Minerva Neurosciences Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NERV – Minerva Neurosciences Inc. yahoo finance google finance

stock history NERV – Minerva Neurosciences Inc. invest stock market

stock prices NERV premarket after hours

ticker NERV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NERV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y